Article Details
Retrieved on: 2022-10-25 13:14:53
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca's Imjudo plus Imfinzi combation received FDA approval for unresectable hepatocellular carcinoma. Credit: AstraZeneca. The US Food and Drug ...
Article found on: www.pharmaceutical-technology.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here